<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01046851</url>
  </required_header>
  <id_info>
    <org_study_id>ISAN-001-09</org_study_id>
    <nct_id>NCT01046851</nct_id>
  </id_info>
  <brief_title>A Study of Nopan Treatment of Acute Suicidality</brief_title>
  <official_title>Phase 3 Study of the Effects of Nopan as add-on Treatment to Antidepressants in Treating Depression and Suicidality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Yoram Yovell</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Haifa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Haifa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anecdotal evidence and several clinical studies found the mixed opioid agonist-antagonist
      Nopan to be an effective antidepressant with a rapid onset of action. It is therefore
      hypothesized that Nopan may be a novel and quick-acting treatment for acute suicidality.
      Depression, suicidality, and overall functioning will be assessed before, during and after a
      four-week Nopan/placebo trial. It is hypothesized that subjects who receive the active drug
      will show rapid improvements in objective and subjective measures of these variables.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in Suicidality as expressed by the score on the BSI</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in depression as measured by the BDI</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Suicidality</condition>
  <arm_group>
    <arm_group_label>Nopan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nopan</intervention_name>
    <description>Nopan(0.2-1.6 mg/day, starting dose=0.2 mg/day, N=40)</description>
    <arm_group_label>Nopan</arm_group_label>
    <other_name>Subotex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo in a manner similar to the active comparator</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  suicidal behavior or ideation (BSI&gt;6)

        Exclusion Criteria:

          -  ECT history within the last month

          -  psychotic features within the last 3 months

          -  history of schizophrenia, substance or alcohol abuse within the last two years

          -  benzodiazepine dependence within the last two years

          -  any significant systemic illness or unstable medical condition which does not permit
             inclusion, according to the research physician

          -  pregnant women

          -  patients who currently suffer from severe impairment or severe dysfunction of liver,
             kidney, adrenal, gall, closed brain injury, urinary retention or respiratory system.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoram Yovell, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Haifa, Institute for the Study of Affective Neuroscience</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mordechai Masiah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Abarbanel MHC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jack Asherov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Edith Wolfson Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nathaniel Laor, MD, PhD, Director</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv- Brill Community Mental Health Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yoram Yovell, MD, PhD</last_name>
    <phone>972-4-8249910</phone>
    <email>isan@research.haifa.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Abarbanel MHC</name>
      <address>
        <city>Bat-Yam</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gali Bar, MA</last_name>
      <email>galibar@bezeqint.net</email>
    </contact>
    <investigator>
      <last_name>Mordechai Masiah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Edith Wolfson Medical Center</name>
      <address>
        <city>Holon</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gali Bar, MA</last_name>
      <email>galibar@bezeqint.net</email>
    </contact>
    <investigator>
      <last_name>Jack Asherov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brill Community Mental Health Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathaniel Laor, MD, PhD, Director</last_name>
      <phone>972-3-5720808</phone>
    </contact>
    <investigator>
      <last_name>Nathaniel Laor, MD, PhD, Director</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2010</study_first_submitted>
  <study_first_submitted_qc>January 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2010</study_first_posted>
  <last_update_submitted>December 31, 2011</last_update_submitted>
  <last_update_submitted_qc>December 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Haifa</investigator_affiliation>
    <investigator_full_name>Prof. Yoram Yovell</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

